Produced by 
NOV 8 - 9 2017
Clinical Diagnostics & Research 2017
20 89 11612

The LabRoots 8th Annual Clinical Diagnostics & Research is now On-Demand!

Clinical diagnostics is an ever-changing field of medicine and research, challenged with combining several different scientific disciplines into one for the sake of diagnosis and treatment of human disease. The constant flux in the field is due to continuous progress made with advances in laboratory testing and patient care and treatment. With new technologies and treatments available, updates in regulatory processes are also necessary to ensure patient safety and proper practices.

Attendees can earn free CME and CE Credits.

By bringing together clinicians, researchers, medical experts and professionals from around the world, LabRoots aims to help drive collaborations and in turn, advances in clinical diagnostics, research and medicine. This complementary conference offers an amazing opportunity to benefit from interacting with a global community of like-minded colleagues from the comfort of home.

Our virtual conference allows you to participate in a global setting with no travel or cost to you. You can participate in exactly those parts which you are interested in and be back at your desk or bench in an instant. Virtual events remove time and place restrictions and ensure that everyone who wants to participate can do so. This virtual conference also offers increased reach for the global clinical community with a high degree of interaction through live-streaming video and chat sessions.

Topics for this years virtual conference included:
 

  • Diagnostic Analysis and Management
  • ABIM/Consumer Reports Choosing Wisely Initiative
  • Mental Health and Healthy Aging
  • Vitamin D
  • Pain Management
  • Evolution Biomarker and Regulation in Clinical Labs


Continuing Education
By participating in this virtual event and watching webcast presentations, you can earn Free Continuing Education (PACE) and/or Continuing Medical Education (CME) credits. To earn educational credits, you must view an entire presentation. Following the presentation you must click on the educational credit link provided for that particular speaker and follow the required process. Once you have completed the process, you will receive a certificate for the educational credit.

Use #LRclinical to follow the conversation!
 


Speakers:

Show Resources
Agenda
All times are Pacific Time
  • NOV 08, 2017 06:00 AM PST
    How Does the ABIM Choosing Wisely Initiative Affect Diagnostic Laboratory Medicine?
    Speaker: George Fritsma, MS MLS
  • NOV 08, 2017 06:00 AM PST
    How to Monitor Heparin Therapy: Still a Controversy
    Speaker: David L. McGlasson, MS. MLS(ASCP)
  • NOV 08, 2017 07:30 AM PST
    Keynote Presentation: The D-Lightful Vitamin D - A Global Perspective
    Speaker: Michael Holick, MD, PhD
  • NOV 08, 2017 09:00 AM PST
    Tough Targets. Simple Genotyping. Complete Solutions for Mitochondrial Disease, CRISPR, Pharmacogenetics, and Neuroscience Research
    Speaker: Dana Sullivan
    Sponsored By: Canon BioMedical
  • NOV 08, 2017 09:00 AM PST
    Vitamin D as a Modifier of Genomic Function and Phenotypic expression During Pregnancy
    Speaker: Bruce Hollis, PhD
  • NOV 08, 2017 10:30 AM PST
    Liquid Chromatography Tandem Mass Spectrometry Research into Testosterone Analysis: Considerations of Instrument Performance Versus Sample Preparation Complexity
    Speaker: Joshua Hayden, PhD, DABCC, FACB
    Sponsored By: Agilent Technologies
  • NOV 08, 2017 12:00 PM PST
    Combined immunohistochemistry and RNA in situ hybridization to elucidate tumor molecular heterogeneity in prostate cancer
    Speaker: Nallasivam Palanisamy, PhD
  • NOV 08, 2017 12:00 PM PST
    Testing for Prostate-Specific Antigen (PSA): To Screen or Not to Screen
    Speaker: Shahram Shahangian, PhD, MS, DABCC, FACB
  • NOV 08, 2017 12:00 PM PST
    The Opioid Crisis and other Novel Psychoactive Substances (NPS): Forensic Toxicological Perspectives
    Speaker: Robert Middleberg, PhD
  • NOV 08, 2017 01:30 PM PST
    Guiding Clinical Laboratory Integration of Next-Generation Sequencing to Assure Quality Testing
    Speaker: Ira Lubin, PhD, FACMG
  • NOV 08, 2017 01:30 PM PST
    Rapid Variant Interpretation and Reporting Using the QIAGEN Knowledgebase and QIAGEN Clinical Insight - Interpret (QCI-I)
    Speaker: Jennifer Poitras, PhD
    Sponsored By: QIAGEN
  • NOV 09, 2017 06:00 AM PST
    Biosafety Risk Assessment Fundamentals for Clinical Laboratories
    Speaker: Michael Pentella, PhD
  • NOV 09, 2017 06:00 AM PST
    Blood trails: nanotechnology-enabled biomarker quantification for early disease detection
    Speaker: Tony Hu, PhD
  • NOV 09, 2017 07:30 AM PST
    Keynote Presentation: Integration of the Simplexa C. difficile Direct assay into a two-step algorithm for the laboratory diagnosis of C. difficile
    Speaker: James Snyder, PhD
  • NOV 09, 2017 09:00 AM PST
    Accelerating Immuno-Oncology Research with the PanCancer IO 360™ Gene Expression Panel, Advanced Data Analysis Service, and Signature Development
    Sponsored By: Nanostring Technologies
    Sarah Warren, PhD
    Director of Advanced Applications Immune Oncology, Nano...
    Patrick Danaher, PhD
    Principal Biostatistician, NanoString
  • NOV 09, 2017 09:00 AM PST
    Monitoring Pain Management Medications in Pregnancy and the Neonate
    Speaker: Gwen McMillin, PhD
  • NOV 09, 2017 10:30 AM PST
    Fast Phenotypic Antibiotic Susceptibility Testing of Positive Blood Cultures
    Speaker: Margie Morgan, PhD, MT(ASCP), D(ABMM)
    Sponsored By: Accelerate Diagnostics
  • NOV 09, 2017 10:30 AM PST
    The Need for Serum 25-hydroxyvitamin D Standardization in Clinical and Research Laboratories
    Speaker: Christopher T. Sempos, PhD
  • NOV 09, 2017 12:00 PM PST
    Is Free 25OH Vitamin D The Next Generation Vitamin D Marker?
    Speaker: Nicolas Heureux
  • NOV 09, 2017 12:00 PM PST
    Understanding T Cell Responses in Tuberculosis-Latest research on QuantiFERON-TB Gold Plus
    Speaker: Jeff Boyle, PhD
    Sponsored By: Qiagen
  • NOV 09, 2017 01:30 PM PST
    Importance of Measuring the Inhibition of Platelet Thromboxanes by Aspirin in Cardiovascular Disease Management and Prevention
    Speaker: Luis Lopez, MD
  • NOV 09, 2017 01:30 PM PST
    The Development and Commercialization of Robust Circulating DNA and RNA Tests
    Speaker: Hestia Mellert, PhD
  • ABIM/Consumer Reports Choosing Wisely Initiative
  • NOV 08, 2017 06:00 AM PST
    How Does the ABIM Choosing Wisely Initiative Affect Diagnostic Laboratory Medicine?
    Speaker: George Fritsma, MS MLS
  • Diagnostic Analysis and Management
  • NOV 08, 2017 06:00 AM PST
    How to Monitor Heparin Therapy: Still a Controversy
    Speaker: David L. McGlasson, MS. MLS(ASCP)
  • NOV 08, 2017 09:00 AM PST
    Tough Targets. Simple Genotyping. Complete Solutions for Mitochondrial Disease, CRISPR, Pharmacogenetics, and Neuroscience Research
    Speaker: Dana Sullivan
    Sponsored By: Canon BioMedical
  • NOV 08, 2017 10:30 AM PST
    Liquid Chromatography Tandem Mass Spectrometry Research into Testosterone Analysis: Considerations of Instrument Performance Versus Sample Preparation Complexity
    Speaker: Joshua Hayden, PhD, DABCC, FACB
    Sponsored By: Agilent Technologies
  • NOV 08, 2017 12:00 PM PST
    Testing for Prostate-Specific Antigen (PSA): To Screen or Not to Screen
    Speaker: Shahram Shahangian, PhD, MS, DABCC, FACB
  • NOV 08, 2017 01:30 PM PST
    Rapid Variant Interpretation and Reporting Using the QIAGEN Knowledgebase and QIAGEN Clinical Insight - Interpret (QCI-I)
    Speaker: Jennifer Poitras, PhD
    Sponsored By: QIAGEN
  • NOV 09, 2017 06:00 AM PST
    Biosafety Risk Assessment Fundamentals for Clinical Laboratories
    Speaker: Michael Pentella, PhD
  • NOV 09, 2017 07:30 AM PST
    Keynote Presentation: Integration of the Simplexa C. difficile Direct assay into a two-step algorithm for the laboratory diagnosis of C. difficile
    Speaker: James Snyder, PhD
  • NOV 09, 2017 10:30 AM PST
    Fast Phenotypic Antibiotic Susceptibility Testing of Positive Blood Cultures
    Speaker: Margie Morgan, PhD, MT(ASCP), D(ABMM)
    Sponsored By: Accelerate Diagnostics
  • NOV 09, 2017 12:00 PM PST
    Understanding T Cell Responses in Tuberculosis-Latest research on QuantiFERON-TB Gold Plus
    Speaker: Jeff Boyle, PhD
    Sponsored By: Qiagen
  • NOV 09, 2017 01:30 PM PST
    Importance of Measuring the Inhibition of Platelet Thromboxanes by Aspirin in Cardiovascular Disease Management and Prevention
    Speaker: Luis Lopez, MD
  • Vitamin D
  • NOV 08, 2017 07:30 AM PST
    Keynote Presentation: The D-Lightful Vitamin D - A Global Perspective
    Speaker: Michael Holick, MD, PhD
  • NOV 08, 2017 09:00 AM PST
    Vitamin D as a Modifier of Genomic Function and Phenotypic expression During Pregnancy
    Speaker: Bruce Hollis, PhD
  • NOV 09, 2017 10:30 AM PST
    The Need for Serum 25-hydroxyvitamin D Standardization in Clinical and Research Laboratories
    Speaker: Christopher T. Sempos, PhD
  • NOV 09, 2017 12:00 PM PST
    Is Free 25OH Vitamin D The Next Generation Vitamin D Marker?
    Speaker: Nicolas Heureux
  • Evolution Biomarker and Regulation in Clinical Labs
  • NOV 08, 2017 12:00 PM PST
    Combined immunohistochemistry and RNA in situ hybridization to elucidate tumor molecular heterogeneity in prostate cancer
    Speaker: Nallasivam Palanisamy, PhD
  • NOV 08, 2017 01:30 PM PST
    Guiding Clinical Laboratory Integration of Next-Generation Sequencing to Assure Quality Testing
    Speaker: Ira Lubin, PhD, FACMG
  • NOV 09, 2017 06:00 AM PST
    Blood trails: nanotechnology-enabled biomarker quantification for early disease detection
    Speaker: Tony Hu, PhD
  • NOV 09, 2017 09:00 AM PST
    Accelerating Immuno-Oncology Research with the PanCancer IO 360™ Gene Expression Panel, Advanced Data Analysis Service, and Signature Development
    Sponsored By: Nanostring Technologies
    Sarah Warren, PhD
    Director of Advanced Applications Immune Oncology, Nano...
    Patrick Danaher, PhD
    Principal Biostatistician, NanoString
  • NOV 09, 2017 01:30 PM PST
    The Development and Commercialization of Robust Circulating DNA and RNA Tests
    Speaker: Hestia Mellert, PhD
  • Pain Management
  • NOV 08, 2017 12:00 PM PST
    The Opioid Crisis and other Novel Psychoactive Substances (NPS): Forensic Toxicological Perspectives
    Speaker: Robert Middleberg, PhD
  • NOV 09, 2017 09:00 AM PST
    Monitoring Pain Management Medications in Pregnancy and the Neonate
    Speaker: Gwen McMillin, PhD
Posters

POSTER SUBMISSION GUIDELINES

Virtual poster sessions offer the opportunity to present data to a global audience via a PDF poster and video summary, and discuss results with interested colleagues through email. Posters should be submitted as a PowerPoint file. Presentations should incorporate illustrative materials such as tables, graphs, photographs, and large-print text. This content is not peer reviewed. Submission is free.

SUBMIT YOUR ABSTRACT

Enter the following information to this Submission Form:

  • Poster Title
  • Your Name
  • Your Institution
  • Your Email
  • Abstract describing the poster

All submitted abstracts will be reviewed and decisions regarding acceptance will be made as abstracts are received. You will be notified within one week of receipt about acceptance. Further details and registration materials will be provided at that time. You do not have to be present in order to have a poster displayed. Only those abstracts approved by LabRoots may display posters at this event.

If accepted, you will also have the opportunity to record a 3-5 minute summary video for each poster. LabRoots will work with each individual to create these videos. Video links and email contact information will be included on each poster displayed.

Questions? Email Posters@LabRoots.com

LabRoots Policy

Speakers

  • James Snyder, PhD
    Professor of Pathology and Laboratory Medicine, University of Louisville
    Biography
      Dr. Snyder is the Medical Director of the Clinical Microbiology & Molecular Diagnostics Laboratory at the University of Louisville Hospital, and Professor of Pathology and Laboratory Medicine in the Department of Pathology and Laboratory Medicine at the University of Louisville, School of Medicine. He has been a part of ASM for many years. He currently serves on the Editorial Board for the Journal of Clinical Microbiology, is a member of the APHL Biosafety/Biosecurity Committee, and a past member of the APHL Sentinel Laboratory Partners Outreach Committee. He is also currently a member of the South Central Association for Clinical Microbiology Audioconference Planning Committee and President Elect of SCACM. He has authored or co-authored over 60 publications and was the recipient of the TREK Diagnostic ABMM/ABMLI Professional Recognition Award at ASM in 2009.
    • Michael Holick, MD, PhD
      Professor of Medicine, Physiology & Biophysics and Director of the Vitamin D, Skin and Bone Research Laboratory and Director of the Bone Healthcare Clinic at Boston University Medical Center
      Biography
        Dr. Holick has made numerous contributions to the field of the biochemistry, physiology, metabolism, and photobiology of vitamin D for human nutrition. Dr. Holick has established global recommendations advising sunlight exposure as an integral source of vitamin D.  He has helped increase awareness in the pediatric and medical communities regarding vitamin D deficiency pandemic, and its role in causing not only metabolic bone disease, and osteoporosis in adults, but increasing risk of children and adults developing common deadly cancers, schizophrenia, infectious diseases including TB and influenza, autoimmune diseases including type 1 diabetes and multiple sclerosis, type 2 diabetes, stroke and heart disease. He also observed the pregnant women who were vitamin D deficient were at increased risk for preeclampsia and requiring a C-section.  He has written more than 300 pier reviewed articles, edited or wrote 12 books including The Vitamin D Solution and is the recipient of numerous awards including the Linus Pauling Prize in Human Nutrition.
      • Jeff Boyle, PhD
        Senior Director: Product and Assay Development North Americas, QIAGEN
        Biography
          Dr. Boyle has over 20 years of experience in immunology research and commercial development relevant to vaccines, biologics and diagnostics. He has published more than 25 papers including Nature, Proc. Natl. Acad. Sci., J. Clin. Microbiol., Vaccine, Int. Immunol. and Transplantation. In addition, he acquired several high-level awards, including top academic achievement each year of undergraduate studies and the Victorian Premiers award for Medical Research. Currently he has an assay development focus on utilizing whole blood assays of cellular immune function for providing insights into unmet medical needs in infectious diseases and transplantation. He is an inventor on several patents relevant to current products and played key roles in leading teams necessary for taking them from concept through to registration.
        • Patrick Danaher, PhD
          Principal Biostatistician, NanoString
          Biography
            Patrick Danaher leads the biostatistics team at NanoString Technologies. Prior to joining NanoString, he earned his Ph.D. at the University of Washington Department of Biostatistics, working with Pei Wang on analysis methods for high-throughput genomics data. He began his career in gene expression at XDx, one of the first gene expression diagnostics companies.
          • George Fritsma, MS MLS
            Proprietor, The Fritsma Factor, Your Interactive Hemostasis Resource
            Biography
              George Fristma manages www.fritsmafactor.com, The Fritsma Factor, Your Interactive Hemostasis Resource, an informational blog supported by Precision BioLogic, Inc, Dartmouth, Nova Scotia and is the education director for BioMedica Diagnostics, Inc., Windsor, Nova Scotia. George is a consultant for the Laboratory Medicine Division of the Pathology Department, University of Alabama at Birmingham School of Medicine, where he provides lectures for pathology residents and for hematology and pathology fellows. George is an associate professor for Rutgers University and Michigan State University, where he provides web-based instructions in hematology and hemostasis. George provides international seminars and webinars in hemostasis and hematology. George is an author for Rodak's Hematology, 5th edition, 2016, Elsevier; and for Quick Guide to Blood Collection, 2nd Edition, 2016, Statistics and Quality Control, 2012; and Quick Guide to Renal Disease Testing, 2011. He is a consulting editor for the Clinical Laboratory Science journal. George holds a bachelor's in biology and chemistry from Calvin College, Grand Rapids, Michigan, a Masters in Medical Technology from Wayne State University, Detroit, and advanced course work from Illinois State University and the University of Illinois at Chicago.
            • Joshua Hayden, PhD, DABCC, FACB
              Assistant Professor of Pathology and Laboratory Medicine at Weill Cornell Medical College
              Biography
                Dr. Hayden is a board certified clinical chemist with a special interest in the development and implementation of new diagnostics, in particular mass spectrometry-based assays for small molecule analysis. Dr. Hayden obtained a PhD in chemistry from Carnegie Mellon University and went on to conduct postdoctoral research at the Massachusetts Institute of Technology. He then completed a two-year clinical chemistry fellowship at the University of Washington, where he trained under the mentorship of Dr. Geoffrey Baird and Dr. Andrew Hoofnagle. He currently is an assistant professor at Weill Cornell Medical College where he serves as Director of the Toxicology and Therapeutic Drug Monitoring laboratory and Assistant Director of the Central Laboratory at Weill Cornell/New York Presbyterian Hospital.
              • Nicolas Heureux
                Principal Scientist, DIAsource ImmunoAssays
                Biography
                  Educated as an Organic Chemist at the Catholic University of Louvain, Belgium (1997-2001), PhD thesis awarded by the Catholic University of Louvain (2001-2006) in the field of total synthesis of biologically active natural alkaloids, under the supervision of Prof. I.E. Markó. One year post-doctoral stay in the Netherlands (2006-2007, Groningen), in the field of nanotechnologies and surface chemistry under the supervision of recently awarded Nobel prize Prof. B. Feringa. Short experience as Project Manager in a small biotech company (Unibioscreen, Bruxelles, Belgium) in the field of extraction and modification of anticancer molecules. Three years as Process improvement team leader at UCB Pharma (2008-2010, Braine-l'Alleud, Belgium) improving the chemical production of active pharmaceutical ingredients at lab-, pilot- and industrial scale. Join DIAsource Immunoassays in 2010 as R&D and Industrialization Project Manager, working on the development and lifecycle management of immunoassays with a strong focus on Vitamin D assays, then move to the current position in early 2014 supporting the DIAsource Vitamin D segment for all scientific and technical aspects.
                • Bruce Hollis, PhD
                  Professor, Pediatrics, Biochemistry and Molecular Biology, Director of Pediatric Nutritional Sciences, Medical University of South Carolina
                  Biography
                    Bruce W. Hollis, Ph.D. received his B.Sc. and M.Sc. from the Ohio State University and subsequently his Ph.D. from the University of Guelph in 1979. Dr. Hollis then completed an Endocrine Fellowship at The Case Western Reserve University School of Medicine in 1982. Dr. Hollis was then Appointed Assistant Professor of Nutrition at Case Western and remained there until 1986 when he moved to The Medical University of South Carolina where to he is Professor of Pediatrics, Biochemistry and Molecular Biology. He is also Director of Pediatric Nutritional Sciences. Dr. Hollis has studied vitamin D metabolism and nutrition for the past 35 years and has been an NIH grant recipient for the past 30 years. His current work focuses on the vitamin D requirements during pregnancy and lactation. Dr. Hollis has in excess of 200 peer reviewed articles in this area of investigation.
                  • Tony Hu, PhD
                    Associate Professor, Biodesign Institute, Arizona State University
                    Biography
                      Tony Hu is an Associate Professor at the Biodesign Institute at Arizona State University's Virginia G. Piper Center for Personalized Diagnostics and at the Ira A. Fulton Schools of Engineering's School of Biological and Health Systems Engineering. Hu's research focuses on developing and validating integrated nanotechnique-based strategies for marker discovery and molecular diagnostics in peripheral blood samples to provide a translatable solution for personalized medicine. His innovations aim to fill current gaps in early detection, real-time therapy monitoring and effective prognostics. He has assembled a diverse team with backgrounds in biochemistry, mass spectrometry, nanofabrication, and biomedical engineering to answer these needs. Hu received his Ph.D. in Biomedical Engineering from the University of Texas at Austin where he focused on developing nanomaterials as biosensors for disease diagnosis. He has published more than 50 journal articles and has received five U.S. patents (issued and pending) on these subjects since his first faculty appointment in 2011. Hu has also published four nanomedicine-related book chapters, and has given more than 40 seminars and invited presentations at major international scientific conferences. His research team has a history of grants from the NCI, NIAID, NICHD and DOD and awards from the Gates, Dunn, Kostas, and Cockrell family foundations. His team has in-depth knowledge of multiplex-detection method development for sample processing, mass spectrometry, biomarker identification and validation. This background ideally positions his team for a leadership role in these fields and for optimal clinical translation of their platforms for improved and comprehensive analysis of blood-based biomarkers that have broad potential clinical applications.
                    • Luis Lopez, MD
                      Medical Director, Corgenix Inc.
                      Biography
                        Luis R. Lopez, M.D., is the founder of Corgenix, Inc. (Broomfield, Colorado, USA) and currently serves as the Company's Medical Director. He received his MD degree in Lima, Peru, with Internal Medicine residency and postgraduate training in Clinical Immunology and Rheumatology at the University of Colorado Health Sciences Center in Denver Colorado. Dr. Lopez has worked in the field of immunodiagnostic of systemic autoimmune diseases including autoimmune-mediated atherothrombotic syndromes such as systemic lupus erythematosus (SLE) and antiphospholipid syndrome (APS). Recent work and publications have included serologic biomarkers to assess the risk of atherosclerotic cardiovascular diseases (CVD) such as oxidized low-density lipoprotein, ß2-Glycoprotein I and CRP complexes as well as pro-thrombotic platelet (urinary thromboxanes, 11dhTxB2) and inflammatory-derived F2-Isoprostanes metabolites.
                      • Ira Lubin, PhD, FACMG
                        Senior Project Lead, Geneticist at the Centers for Disease Control and Prevention
                        Biography
                          Dr. Ira M. Lubin is a senior scientist within the Division of Laboratory Systems at the Centers for Disease Control and Prevention. He is Clinical Molecular Geneticist certified by the American Board of Medical Genetics. Dr. Lubin has led or otherwise participated in both national and international efforts to advance the quality of laboratory practice during his 18-year tenure at CDC, working extensively with federal, academic, and commercial partners. In 2010, he next-generation sequencing (NGS) was added to his list of interests. He helped to initiate and co-lead the Next-Generation Sequencing: Standards for Clinical Testing (Nex-SToCT) series of national workgroups that culminated in three consensus guidance documents that served to inform evolving practices and standards both domestically and globally. Dr. Lubin co-Chaired the Clinical and Laboratory Standards Institute Document Development Committee that produced the guideline - Nucleic Acid Sequencing Methods in Diagnostic Laboratory Medicine that provided significant attention to NGS. He has provided input to the evolving FDA framework for NGS by serving as an invited presenter at several workshops. He has also presented to the Clinical Laboratory Improvement Amendments in providing input relevant to the oversight of NGS implemented in clinical laboratory settings. Internationally, Dr. Lubin has been an invited presenter to the European clinical laboratory community and participated in the review of NGS guidelines developed by EuroGenTest.
                        • David L. McGlasson, MS. MLS(ASCP)
                          Clinical Research Scientist, 59th CRD
                          Biography
                            David L. McGlasson, MS. MLS(ASCP)cm was a staff researcher at the 59th Clinical Research Division at Lackland JBSA in San Antonio, TX until his retirement.. He has published 166 abstracts, 76 manuscripts, 9 book chapters, three patents and one book. Mr. McGlasson has also presented more than 200 lectures at local, state, national and international levels. He is the 9 time winner of the American Clinical Laboratory Science Award for scientific research and has received the Kendall-Sherwood Award, the Bio-Rad award for scientific achievement in Hematology. He also has won numerous poster competitions at many meetings. To include the Society of Armed Forces Laboratory Science, International Society of Thrombosis and Hemostasis and American Society of Clinical Laboratory Science. He currently is a consulatant in the area of Hemostasis and Thrombosis.
                          • Gwen McMillin, PhD
                            Medical Director, Toxicology and Pharmacogenetics, ARUP Laboratories
                            Biography
                              Dr. McMillin is a professor of pathology at the University of Utah School of Medicine. She received her PhD in pharmacology and toxicology from the University of Utah and is certified by the American Board of Clinical Chemistry in clinical chemistry and toxicological chemistry. Dr. McMillin is actively involved in professional associations such as the International Association of Therapeutic Drug Monitoring and Clinical Chemistry (IATDMCT), the American Association for Clinical Chemistry (AACC), and the College of American Pathologists (CAP). Her primary interests include detection of neonatal drug exposures, as well as clinical applications and implementation of pharmacogenomics.
                            • Hestia Mellert, PhD
                              Director, Molecular Development at Biodesix
                              Biography
                                Dr. Mellert is a Director within the Biodesix Development group. She has a background in molecular cancer biology and experience leading teams in the development and commercialization of blood-based diagnostic tests under CAP/CLIA and NYS CLEP. Dr. Mellert has played a leading role in the support of GeneStrat including the launch of EML4-ALK, ROS1 and RET fusion tests out of blood. She continues to focus her efforts on bringing relevant and actionable information to physicians in the academic and community setting. Dr. Mellert received her Ph.D from the University of Pennsylvania and post-doctoral training at the University of Colorado. She has received a number of awards including the American Cancer Society Post-doctoral fellowship.
                              • Robert Middleberg, PhD
                                Sr. Vice President, Quality Assurance Laboratory Director & Forensic Toxicologist, NMS Labs
                                Biography
                                  Robert A. Middleberg is the Laboratory Director and Senior VP of Laboratory Operations and Quality Assurance at NMS Labs. He is a Fellow of the American Board of Forensic Toxicology and a Diplomate of the American Board of Clinical Chemistry, and currently sits as a Board Director of the ABFT and recently completed his tenure on the Board of Directors of ABCC. He served as Toxicology Section Chair within AAFS, and was Chair of the Scientific Working Group in Toxicology from its beginning to its end in 2014. He currently is a member of CAP's Toxicology Resource Committee, and sits on the Toxicology Subcommittee within the NIST OSAC. In 2013, Dr. Middleberg was awarded the Rolla N. Harger Award by the Toxicology section of the American Academy of Forensic Sciences for his contributions to the field and profession of forensic toxicology.
                                • Margie Morgan, PhD, MT(ASCP), D(ABMM)
                                  Professor of Pathology and Laboratory Medicine, Scientific Director and Microbiology, Cedars-Sinai Medical Center
                                  Biography
                                    I am a clinical microbiologist and currently the scientific director of microbiology at Cedars- Sinai Medical Center in Los Angeles, CA. I love to teach, and during my thirty years in microbiology I have taught enumerable pathology residents, infectious disease fellows, pharmacists, infection control nurses, and clinical laboratory scientists. I have reviewed hundreds of pathology residents for their board examination at the Osler Institute Pathology Review Course. It has been my goal to spread the science and art of microbiology to whoever would look and listen. I love to teach microbiology!
                                  • Nallasivam Palanisamy, PhD
                                    Associate Scientist, Henry Ford Health System
                                    Biography
                                      Dr. Palanisamy completed his undergraduate and graduate studies at the University of Madras, India, and is currently an Associate/Senior Scientist at the Henry Ford Health System. He also holds an adjunct faculty appointment with the Michigan Center for Translational Pathology (MCTP) at the University of Michigan. His current research program is focused on the discovery of cancer biomarkers in lymphomas and solid cancers. During his post-doctoral research at the Memorial Sloan-Kettering Cancer Center, Dr. Palanisamy's work contributed to the discovery of recurrent gene fusions in follicular and diffuse large B-cell lymphomas. He was the founding Director of Research and Development at the Cancer Genetics, Inc (CGIX), where he introduced novel approaches to develop diagnostic reagents targeting chromosomal translocations in cancer. Dr. Palanisamy pioneered the application of next generation sequencing technology for transcriptome sequencing and discovered novel "druggable" gene fusions in prostate cancer, gastric cancer, and melanoma (Palanisamy et al., Nat Med 2010). His current research aims to understand the molecular basis of tumor heterogeneity in solid cancers, with particular focus on prostate cancer, and its impact in early diagnosis, response to treatment, and clinical outcome.
                                    • Michael Pentella, PhD
                                      Clinical Professor at the University of Iowa, College of Public Health
                                      Biography
                                        Dr. Pentella is a Clinical Professor at the University of Iowa, College of Public Health. His experience spans over forty years in clinical microbiology and public health laboratories. He is certified as an American Board of Medical Microbiology Diplomate and serves on a number of national commitees.
                                      • Jennifer Poitras, PhD
                                        Principal Genome Scientist, QIAGEN
                                        Biography
                                          Jennifer received a B.S. in Genetics from the University of Connecticut and went on to receive a Ph.D. in Human Genetics at the Johns Hopkins School of Medicine. During her graduate training, she used Ingenuity Pathway Analysis and was so impressed with the tool that she approached QIAGEN for the opportunity to support their bioinformatics portfolio. Currently, she is the lead genome scientist supporting QIAGEN's software solutions for analysis and interpretation of variants implicated in hereditary disease.
                                        • Dana Sullivan
                                          Product Manager, Canon Biomedical
                                          Biography
                                            Dana Pfister Sullivan received her Masters in Biotechnology, from Johns Hopkins University, with a focus in molecular targets and drug design. She has worked in various areas of the biotechnology industry, including pharmaceutical, life science, and molecular diagnostic in both research and development as well as commercial. Dana has five years of practical experience at the laboratory bench, and her work has been published in peer-reviewed journals and presented at international conferences. Dana joined Canon BioMedical as Product Manager shortly after the first launch of the Novallele Genotyping Assays. She is passionate about partnering with life scientists and researchers to develop the next wave of biomedical solutions.
                                          • Christopher T. Sempos, PhD
                                            Coordinator, Vitamin D Standardization Program (VDSP), NIH Office of Dietary Supplements
                                            Biography
                                              Christopher T. Sempos, Ph.D., a Nutritional Epidemiologist and Program Director for the Population Studies Program in the NIH Office of Dietary Supplements (ODS) since 2008, retired in July 2015 after more than 27 years of federal government service. Dr. Sempos is now a part-time consultant with ODS who is continuing to serve as coordinator of the Vitamin D Standardization Program (VDSP). VDSP is an international collaborative effort to standardize the laboratory measurement of vitamin D status. Dr. Sempos's research areas are in nutritional epidemiology, especially cardiovascular and alcohol epidemiology, nutrition monitoring and public health surveillance methods, dietary survey methods, and biostatistics. Since coming to ODS, his research has focused serum 25-hydroxyvitamin D. The author of more than 100 professional and technical papers, he is also the co-author of the textbook,Statistical Methods in Epidemiology. His work has included numerous papers using data from NHANES including research on iron as a risk factor for heart disease, and national trends in diet and biomarkers of diet. Dr. Sempos received his Ph.D. in Nutritional Sciences from the University of Wisconsin-Madison in 1982. At the same time he earned an M.S. in Preventive Medicine-Epidemiology. He completed an NIH postdoctoral fellowship in Biostatistics, Nutrition, Preventive Cardiology and Cardiovascular Epidemiology at the Northwestern University Medical School, Department of Community Health and Preventive Medicine in Chicago, IL, and a postdoctoral fellowship with the U.S. Food and Drug Administration (FDA). From 1999-2004, he was Professor of Epidemiology and Director of Graduate Studies in the Department of Social and Preventive Medicine, University of Buffalo. He also worked in several positions within the Public Health Service from 1983-1999, most notably as Chief, Longitudinal Studies for the Division of Health and Nutrition Examination Surveys (DHANES) at the National Center for Health Statistics (NCHS), Centers for Disease Control and Prevention (CDC).
                                            • Shahram Shahangian, PhD, MS, DABCC, FACB
                                              Senior Health Scientist, Laboratory Research & Evaluation Branch, Division of Laboratory Systems, Centers for Surveillance, Epidemiology, & Laboratory Services, Centers for Disease Control
                                              Biography
                                                Dr. Shahram Shahangian has been a senior health scientist at the CDC's Division of Laboratory Systems since 1993. During this time, Dr. Shahangian has conducted studies in various areas of clinical laboratory medicine including clinical laboratory performance and proficiency testing, appropriate laboratory test utilization, problems in the total laboratory testing process, national surveys of coagulation laboratory testing practices, critical review of clinical laboratory quality indicators, and publications of good laboratory practices in molecular genetic testing, biochemical genetic tests, and newborn screening. He is the first or sole author of 25 original articles published in various peer-reviewed clinical laboratory journals. Prior to joining the CDC, Dr. Shahangian worked as a technical director and senior scientist in several biotechnology firms (1989-1993), as a research faculty member at the University of Texas MD Anderson Center (1985-1989), and as a postdoctoral fellow in clinical chemistry at the University of Utah School of Medicine (1982-1984). Dr. Shahangian received his PhD in 1982 and MS in 1979, both in biochemistry, from the University of Illinois at Urbana-Champaign. He has been a diplomate of the American Board of Clinical Chemistry since 1994 and a fellow of the National Academy of Clinical Biochemistry since 1995.
                                              • Sarah Warren, PhD
                                                Director of Advanced Applications Immune Oncology, NanoString
                                                Biography
                                                  Sarah Warren is the Directors of Advanced Applications & Immune Oncology at NanoString where she leads IO collaborations and leads teams focused on new application development, IO product development, and the NanoString commercial lab. Prior to joining NanoString, she was a founder and Director of Research at Oncofactor, a startup biotech developing novel immune checkpoint therapeutics. She holds a PhD in immunology from the University of Washington and did her graduate research at the Institute for Systems Biology studying host-pathogen interactions.
                                                Sponsored By

                                                For information on becoming a sponsor or exhibitor, please click here.


                                                Continuing Education (CME/CE/CEU) Credits

                                                The speakers below have been approved for CME, CE, or CEU credits. To redeem your credits, locate the presentation you watched and click on the CME/CE/CEU buttons for further direction. For more general information regarding continuing education, the processes to receive credits, and the accreditation bodies, Click here

                                                The presentational method for this activity will be Lecture with an opportunity for real-time question and answer periods for the live activity, and on demand access of the presentation for the enduring material activity. Both the internet live course and the internet activity enduring material are geared towards Laboratory Clinicians, Primary Care Clinicians, and those involved in clinical testing and diagnostics. This activity will encompass the following desirable physician attributes:  Patient Care & Procedural Skills, Medical Knowledge, Professionalism, Interpersonal & Communication Skills, Practice-Based Learning & Improvement, and Systems-Based Practice.

                                                Desired Outcomes

                                                At the end of the activity, participants should be able to:

                                                1. Ability to contrast previous and newly released guidelines
                                                2. Take action to increase partnership and collaboration with clinicians
                                                3. Identify actions that can be taken to deliver quality results faster to clinicians
                                                4. Better define personalized healthcare today and explain the role of companion diagnostics
                                                5. Utilize diagnostic tools optimally in-patient work-ups
                                                6. Identify the role of the clinical laboratory in contributing to or preventing diagnostic errors

                                                This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME®) through the joint providership of CME Consultants and LabRoots. CME Consultants is accredited by the ACCME® to provide continuing medical education for physicians.

                                                CME Consultants designates this internet live activity for a maximum of 5.0 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

                                                CME Consultants designates this internet live activity enduring material for a maximum of 5.0 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

                                                Enduring Material release date: 11/10/17

                                                Enduring Material Termination date: 5/10/18

                                                In accordance with the Americans with Disability Act (ADA), please contact LabRoots at ce@labroots.com should you require special assistance.


                                                Committee

                                                To download the Program Committee brochure here.


                                                • Sihe Wang, PhD DABCC FACB

                                                  Dr. Sihe Wang is Section Head and Medical Director of Clinical Biochemistry and Director of Clinical Biochemistry Fellowship Training Program, Cleveland Clinic, Cleveland, Ohio. He also chairs the clinical chemistry integration effort for the Cleveland Clinic Health System which ...

                                                  See more See less
                                                • George Fritsma, MS, MT

                                                  George Fritsma is an associate professor in Laboratory Medicine of the Department of Pathology at the University of Alabama at Birmingham. Prof. Fritsma manages www.fritsmafactor.com, "The Fritsma Factor, Your Interactive Hemostasis Resource," a clinical coagulation ...

                                                  See more See less
                                                • Wieslaw Furmaga, MD

                                                  Director, Clinical Chemistry Laboratory University Hospital Director, General Laboratory Cancer Treatment Research Center Director, Proteomics Laboratory UTHSC at San Antonio Interim Director, Molecular Laboratory UTHSC at San Antonio Associate Director, Mycology Laboratory UTHSC ...

                                                  See more See less
                                                • Michael Holick, MD, PhD

                                                  Michael F. Holick, Ph.D., M.D. is Professor of Medicine, Physiology and Biophysics; Director of the General Clinical Research Unit; and Director of the Bone Health Care Clinic and the Director of the Vitamin D, Skin and Bone Research Laboratory at Boston University Medical ...

                                                  See more See less
                                                • Bruce Hollis, PhD

                                                  Bruce W. Hollis, Ph.D. received his B.Sc. and M.Sc. from the Ohio State University and subsequently his Ph.D. from the University of Guelph in 1979. Dr. Hollis then completed an Endocrine Fellowship at The Case Western Reserve University School of Medicine in 1982. Dr. Hollis ...

                                                  See more See less
                                                • Kamisha Johnson-Davis, PhD, DABCC, FACB

                                                  Dr. Johnson-Davis is a medical director of the Clinical Toxicology laboratory, Antifungal Testing and Immunosuppressants Testing at ARUP. Dr. Johnson-Davis received her PhD in pharmacology at the University of Utah and is board certified in clinical chemistry by the American ...

                                                  See more See less
                                                • Alan Maisel, MD

                                                  Dr. Alan Maisel attended University of Michigan Medical School and did his cardiology training at the University of California at San Diego. He is currently Professor of Medicine at the University and director of the coronary care unit and the heart failure program at the ...

                                                  See more See less
                                                • Mark Marzinke, PhD, BABCC

                                                  Mark Marzinke, PhD, DABCC earned a Ph.D. in Biochemistry from the University of Wisconsin-Madison and subsequently completed a clinical chemistry fellowship at The Johns Hopkins University in 2012. During his clinical fellowship, Dr. Marzinke focused on the development and ...

                                                  See more See less
                                                • Alan Wright, MD

                                                  Dr. Wright is the Chief Medical Officer at Roche Diagnostics Corporation in Indianapolis, Indiana. Prior to joining Roche, Dr. Wright served as Senior Vice President of Health Improvement Strategies for Miraca Life Sciences. He was the Vice President for Product Strategy and ...

                                                  See more See less
                                                • Damien Gruson, PhD, EuSpLM, FESC

                                                  Professor Damien Gruson was awarded his degree of Pharmacist in 2000 and of Specialist in Laboratory Medicine in 2005 from the Catholic University of Louvain, Brussels, Belgium. Pr. D. Gruson fulfilled is PhD thesis entitled "Regulation and Physiopathology of Urotensin II and ...

                                                  See more See less
                                                Help

                                                General LabRoots Questions

                                                For bugs, spam, technical support or questions please call +1-714-463-4673 or email support@labroots.com  
                                                Contact us

                                                Virtual Events and Webinars

                                                Supported Configurations

                                                • Operating System Internet Explorer Firefox Chrome Safari
                                                  Vista IE8+ FF10+ Chrome15+
                                                  Windows 7 IE8+ FF10+ Chrome15+
                                                  Windows 8 IE10 FF10+ Chrome15+
                                                  Mac OS X   FF10+ Chrome15+ Safari5.1+
                                                • Cookie settings: session cookies enabled
                                                • Browser configuration must have JavaScript enabled
                                                • Adobe Flash player 10.2 or later

                                                To watch our webinars and virtual events a modern browser such as Chrome, Firefox, Safari, or an updated version of Internet Explorer is required.

                                                Internet Connection

                                                • A minimum of 100Kbps is recommended for audio-only events
                                                • A minimum of 300Kbps is recommended for speaker on-video events

                                                Computer Equipment

                                                • Screen Resolution: Minimum 1024x768
                                                • Video Card: 65,000 colors minimum
                                                • Sound card and speakers (or headphones) for hearing webcast in full format
                                                • Audio Card: 16-bit minimum
                                                • RAM: 512MB of free RAM

                                                Firewall Protocol

                                                • HTTP on port 80 or HTTPS on port 443
                                                • Adobe RTMP on port 1935, 80, or 443 with automatic fall-back to RTMPT (RTMP tunneling) on ports 1935, 80 or 443
                                                • RTMPE (RTMP encrypted) on ports 1935, 80 or 443

                                                Work-At-Home Attendees

                                                • If a corporate VPN is used, confirm that your network traffic is not directed over the company VPN. If it is, please turn off the VPN while attending the virtual event.

                                                For A Seamless Experience

                                                When using a mobile device, FREE Mobile Apps are available:

                                                - For viewing Webinars:

                                                - For viewing Virtual Events

                                                Attendee Guide

                                                • To learn more about how the virtual event works for attendees, download the Attendee Guide (PDF).

                                                Virtual Event and Webinar Support:

                                                Continuing Education (CME/CE) Support

                                                Show Resources
                                                Connect with us